tiprankstipranks
Capricor Therapeutics (CAPR)
NASDAQ:CAPR
Holding CAPR?
Track your performance easily

Capricor Therapeutics (CAPR) Financial Statements

881 Followers

Capricor Therapeutics Financial Overview

Capricor Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.062; its P/E ratio is -12.31; Capricor Therapeutics is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is $-0.18. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 2.26M$ 3.97M$ 4.91M$ 12.09M$ 6.19M
Gross Profit$ 2.26M$ 3.97M$ 4.91M$ 12.09M$ 6.19M
EBIT$ -12.56M$ -11.00M$ -9.79M$ -1.28M$ -6.86M
EBITDA$ -12.20M$ -10.64M$ -9.46M$ -973.68K$ -6.59M
Net Income Common Stockholders$ -12.56M$ -11.00M$ -9.79M$ -762.09K$ -6.39M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 85.03M$ 29.46M$ 39.92M$ 39.49M$ 28.52M
Total Assets$ 92.95M$ 38.28M$ 49.44M$ 58.73M$ 37.15M
Total Debt$ 5.02M$ 5.21M$ 5.40M$ 5.61M$ 5.79M
Net Debt$ -80.00M$ -24.25M$ -34.52M$ -33.88M$ -22.73M
Total Liabilities$ 24.69M$ 26.78M$ 31.01M$ 36.13M$ 38.94M
Stockholders Equity$ 68.26M$ 11.50M$ 18.43M$ 22.60M$ -1.79M
Cash Flow-
Free Cash Flow$ -11.65M$ -12.35M$ -1.88M$ -12.32M$ -9.43M
Operating Cash Flow$ -11.64M$ -12.29M$ -1.27M$ -11.59M$ -8.79M
Investing Cash Flow$ 2.00M$ 14.70M$ -9.50M$ -5.86M$ 7.72M
Financing Cash Flow$ 67.33M$ 2.07M$ 2.29M$ 23.17M$ 221.08K
Currency in USD

Capricor Therapeutics Earnings and Revenue History

Capricor Therapeutics Debt to Assets

Capricor Therapeutics Cash Flow

Capricor Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis